Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection

NCT03991780 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Rejection

Interventions

DRUG: Fostamatinib

Sponsor

Imperial College London